Pricing of drugs codeveloped by federal laboratories and private companies
Subtitle: hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1993
Place of publication: Washington
Number of pages: 237
Subjects: Drugs -- Prices -- United States.; Orphan drugs -- Prices -- United States.; Drugs -- Research -- United States -- Finance.; Pharmaceutical industry -- United States.